DRUG · Mapped RxNorm record
Ozanimod
Normalized identity: ozanimodView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Assessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS
NCT06334094
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAssessing the Cognitive Benefits of Ozanimod and Their Brain-Biomarkers in MS
Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Multiple Sclerosisverified · MONDO: multiple sclerosis
Interventions
OzanimodDRUG · verified · RxNorm: ozanimod
Sponsors & collaborators
The University of Texas at Dallaslead sponsor
Texas Institute for Neurological Disorderscollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06334094 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.